{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:09:33Z","timestamp":1790788173245,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012269","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000}}],"reference-count":69,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012269.pub2","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T10:43:06Z","timestamp":1657795386000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia"],"prefix":"10.1002","volume":"2022","author":[{"given":"Joseph","family":"Kwan","sequence":"additional","affiliation":[{"name":"Department of Brain Sciences; Imperial College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Hafdi","sequence":"additional","affiliation":[{"name":"Department of Neurology; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine L W","family":"Chiang","sequence":"additional","affiliation":[{"name":"Department of Medicine; The University of Hong Kong, Queen Mary Hospital; Hong Kong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyo K","family":"Myint","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition; University of Aberdeen; Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Siang","family":"Wong","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry J","family":"Quinn","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular and Medical Sciences; University of Glasgow; Glasgow UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD012269.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jalz.2015.04.010","article-title":"The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischaemic small vessel disease: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Jia","year":"2016","journal-title":"Alzheimer's & Dementia: the Journal of the Alzheimer's Association"},{"issue":"7532403","key":"10.1002\/14651858.CD012269.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7532403","article-title":"Longitudinal study on low-dose aspirin versus placebo administration in silent brain infarcts: the SILENCE study","volume":"2018","author":"Maestrini","year":"2018","journal-title":"Stroke Research and Treatment"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S1474-4422(14)70224-8","article-title":"Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial","volume":"13","author":"Pearce","year":"2014","journal-title":"Lancet Neurology"},{"issue":"10","key":"10.1002\/14651858.CD012269.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"2989\u201394","DOI":"10.1161\/STROKEAHA.114.005789","article-title":"Predictors of mortality in patients with lacunar stroke in the Secondary Prevention of Small Subcortical Strokes trial","volume":"45","author":"Sharma","year":"2014","journal-title":"Stroke; a Journal of Cerebral Circulation"},{"issue":"9","key":"10.1002\/14651858.CD012269.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1056\/NEJMoa1204133","article-title":"Effects of clopidogrel added to aspirin in patients with recent lacunar stroke","volume":"367","author":"Benavente","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012269.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1747493016669848","article-title":"ASPREE-NEURO study protocol: a randomized controlled trial to determine the effect of low-dose aspirin on cerebral microbleeds, white matter hyperintensities, cognition, and stroke in the healthy elderly","volume":"12","author":"Ward","year":"2017","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ahj.2016.03.019","article-title":"Effect of apixaban on brain infarction and microbleeds: AVERROES \u2013 MRI assessment study","volume":"178","author":"O'Donnell","year":"2016","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1161\/STROKEAHA.120.029762","article-title":"Rivaroxaban for prevention of covert brain infarcts and cognitive decline: the COMPASS MRI substudy","volume":"51","author":"Sharma","year":"2020","journal-title":"Stroke"},{"issue":"12","key":"10.1002\/14651858.CD012269.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1161\/CIRCULATIONAHA.113.002236","article-title":"Long-term effects of secondary prevention on cognitive function in stroke patients","volume":"128","author":"Douiri","year":"2013","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000338247","article-title":"Effect of cilostazol in acute lacunar infarction based on pulsatility index of transcranial Doppler (ECLIPse): a multicenter, randomized, double-blind, placebo-controlled trial","volume":"69","author":"Han","year":"2013","journal-title":"European Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012269.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.amjcard.2016.04.039","article-title":"Dementia and stroke rates were lower among patients receiving long-term anticoagulation therapy with novel oral anticoagulants compared to warfarin","volume":"118","author":"Jacobs","year":"2015","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD012269.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/STROKEAHA.114.008422","article-title":"Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke pooled analysis of randomised trials","volume":"46","author":"Kwok","year":"2015","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Kwon HM Lynn MJ Turan TN Derdeyn CP Fiorella D Lane BF Sammpris Investigators Frequency, risk factors, and outcome of coexistent small vessel disease and intracranial arterial stenosis: results from the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial JAMA Neurology 2016 73 36 42 10.1001\/jamaneurol.2015.3145. 26618534","DOI":"10.1001\/jamaneurol.2015.3145"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.eclinm.2019.04.001","article-title":"Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: the LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial","volume":"11","author":"Blair","year":"2019","journal-title":"Lancet EClinical Medicine"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s00125-001-0740-2","article-title":"A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with type II diabetes","volume":"45","author":"Shindo-Tagawa","year":"2002","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.21037\/atm.2020.02.137","article-title":"The association of white matter hyperintensities with stroke outcomes and antiplatelet therapy in minor stroke patients","volume":"8","author":"Xu","year":"2020","journal-title":"Annals of Translational Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012269.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijge.2013.12.005","article-title":"Effects of antiplatelet agents on functional outcome and cognitive status in patients with acute ischaemic stroke","volume":"8","author":"Zhang","year":"2014","journal-title":"International Journal of Gerontology"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0018|cit18","unstructured":"Cilostazol verse aspirin for vascular dementia in poststroke patients with white matter lesions (CAVAD) clinicaltrials.gov\/ct2\/show\/NCT00847860"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0019|cit19","unstructured":"Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non-valvular atrial fibrillation (CAF) clinicaltrials.gov\/ct2\/show\/NCT03061006"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0020|cit20","unstructured":"Efficacy study of cilostazol and aspirin on cerebral small vessel disease (Challenge) clinicaltrials.gov\/ct2\/show\/NCT01932203"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0021|cit21","unstructured":"Cilostazol in retarding progression of cerebral white matter hyperintensities www2.ccrb.cuhk.edu.hk\/registry\/public\/269\/history\/1495"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0022|cit22","unstructured":"Efficacy of Clopidogrel on Incidence of Silent Brain Infarction (ECISBI) clinicaltrials.gov\/ct2\/show\/NCT04698031"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0023|cit23","unstructured":"LACunar Intervention (LACI-2) Trial-2 (LACI-2) clinicaltrials.gov\/ct2\/show\/NCT03451591"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0024|cit24","unstructured":"Efficacy study of cilostazol and aspirin on cerebral small vessel disease (Challenge) clinicaltrials.gov\/ct2\/show\/NCT01932203"},{"issue":"8","key":"10.1002\/14651858.CD012269.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.04.028","article-title":"Design and rationale for a cognitive outcome substudy in ischemic stroke patients with high risk of cerebral hemorrhage","volume":"25","author":"Yu","year":"2016","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"3","key":"10.1002\/14651858.CD012269.pub2-BIB0026|cit26","first-page":"1","article-title":"Aspirin for the prevention of cognitive decline in the elderly: rationale and design of a neuro-vascular imaging study (ENVIS-ion)","volume":"12","author":"Reid","year":"2012","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"642","DOI":"10.2174\/15672050113109990037","article-title":"Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia","volume":"10","author":"Akinyemi","year":"2013","journal-title":"Current Alzheimer Research"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1747493016666091","article-title":"Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack","volume":"13","author":"Arba","year":"2018","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012269.pub2-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013306.pub2","article-title":"Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis","author":"Battle","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012269.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2196\/jmir.5218","article-title":"Web-based interventions targeting cardiovascular risk factors in middle-aged and older people: a systematic review and meta-analysis","volume":"18","author":"Beishuizen","year":"2016","journal-title":"Journal of Medical Internet Research"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.eclinm.2019.04.001","article-title":"Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: the LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial","volume":"11","author":"Blair","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000441420","article-title":"Visual assessment of age-related white matter hyperintensities using FLAIR images at 3T: inter- and intra-rater agreement","volume":"16","author":"Boutet","year":"2016","journal-title":"Neurodegenerative Diseases"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"e004301","DOI":"10.1136\/bmjopen-2013-004301","article-title":"Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation","volume":"4","author":"Cameron","year":"2014","journal-title":"British Medical Journal Open"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","article-title":"Population-based norms for the Mini-Mental State Examination by age and educational level","volume":"269","author":"Crum","year":"1993","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.sleep.2014.10.023","article-title":"Poor sleep quality and silent markers of cerebral small vessel disease: a population-based study in community-dwelling older adults (the Atahualpa Project)","volume":"16","author":"Del Brutto","year":"2015","journal-title":"Sleep Medicine"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","article-title":"Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study","volume":"7","author":"Diener","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000108861","article-title":"Lacunar infarcts \u2013 a review","volume":"1","author":"Fisher","year":"1991","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1741-7015-8-36","article-title":"Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis","volume":"8","author":"Geeganage","year":"2010","journal-title":"BMC Medicine"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0040|cit40","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1742-2094-8-26","article-title":"Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease","volume":"8","author":"Grammas","year":"2011","journal-title":"Journal of Neuroinflammation"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1586\/ern.09.73","article-title":"Mild cognitive impairment in stroke patients with ischaemic cerebral small-vessel disease: a forerunner of vascular dementia?","volume":"9","author":"Grau-Olivares","year":"2009","journal-title":"Expert Review of Neurotherapeutics"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0043|cit43","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00401-010-0718-6","article-title":"The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia","volume":"120","author":"Iadecola","year":"2010","journal-title":"Acta Neuropathology"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11883-014-0449-6","article-title":"Antiplatelet strategies for secondary prevention of stroke and TIA","volume":"16","author":"Ishida","year":"2014","journal-title":"Current Atherosclerosis Report"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Knopman","year":"2010","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD012269.pub2-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011459.pub2","article-title":"Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia","author":"Jordan","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012269.pub2-BIB0048|cit48","first-page":"28","article-title":"Prevalence and clinical impact of white matter hyperintensities, cerebral microbleeds, and medial temporal lobe atrophy on short- and long-term outcomes after stroke rehabilitation","volume":"22","author":"Kwan","year":"2016","journal-title":"Hong Kong Medical Journal"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1001\/jama.2015.4369","article-title":"Stroke prevention in atrial fibrillation: a systematic review","volume":"313","author":"Lip","year":"2015","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012269.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003154.pub6","article-title":"Memantine for dementia","author":"McShane","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD012269.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ageing\/afw104","article-title":"Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review","volume":"45","author":"Moffitt","year":"2016","journal-title":"Age Ageing"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5853\/jos.2015.17.2.111","article-title":"Prevention and management of cerebral small vessel disease","volume":"17","author":"Mok","year":"2015","journal-title":"Journal of Stroke"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3109\/09540261.2013.838151","article-title":"Cerebral white matter hyperintensities in the prediction of cognitive decline and incident dementia","volume":"25","author":"Mortamais","year":"2013","journal-title":"International Review of Psychiatry"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5853\/jos.2015.17.2.94","article-title":"Evolving concept of small vessel disease through advanced brain imaging","volume":"17","author":"Norrving","year":"2015","journal-title":"Journal of Stroke"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/agm2.12073","article-title":"Clinical practice guideline for cognitive impairment of cerebral small vessel disease","volume":"2","author":"Peng","year":"2019","journal-title":"Aging Medicine (Milton)"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and meta-analysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer's & Dementia"},{"issue":"1","key":"10.1002\/14651858.CD012269.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2012.06.012","article-title":"Methodological challenges in designing dementia prevention trials \u2013 the European Dementia Prevention Initiative (EDPI)","volume":"322","author":"Richard","year":"2012","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/1871527314666150217123147","article-title":"Vascular risk factors and Alzheimer's disease pathogenesis: are conventional pharmacological approaches protective for cognitive decline progression?","volume":"14","author":"Safouris","year":"2015","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/bmj.a139","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Sch\u00fcnemann","year":"2008","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00125-001-0740-2","article-title":"A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes","volume":"45","author":"Shinoda-Tagawa","year":"2002","journal-title":"Diabetologia"},{"issue":"6","key":"10.1002\/14651858.CD012269.pub2-BIB0062|cit62","first-page":"e44","article-title":"Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Smith","year":"2017","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: mechanisms and clinical implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012269.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/23969873211012132","article-title":"ESO Guideline on covert cerebral small vessel disease","volume":"6","author":"Wardlaw","year":"2021","journal-title":"European Stroke Journal"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2012.11.006","article-title":"The worldwide economic impact of dementia 2010","volume":"9","author":"Wimo","year":"2013","journal-title":"Alzheimers Dementia"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/postgradmedj-2020-137916","article-title":"Antithrombotic therapy and the risk of new-onset dementia in elderly patients with atrial fibrillation","volume":"12","author":"Wong","year":"2020","journal-title":"Postgraduate Medicine Journal"},{"key":"10.1002\/14651858.CD012269.pub2-BIB0068|cit68","volume-title":"World Alzheimer Report 2015","author":"Prince","year":"2015"},{"issue":"7","key":"10.1002\/14651858.CD012269.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012269","article-title":"Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia","author":"Kwan","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:01:35Z","timestamp":1753441295000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012269.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":69,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012269.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]}}}